<DOC>
	<DOCNO>NCT00427180</DOCNO>
	<brief_summary>Investigate whether blind subject fulfil patient criterion provide Retinal Implant able differentiate simple pattern like horizontal bar , vertical bar cross .</brief_summary>
	<brief_title>IRIS PILOT - Extended Pilot Study With Retinal Implant System</brief_title>
	<detailed_description>The Retinal Implant System consist three main component , Retinal Stimulator , component actually implant eye , visual interface , Pocket Processor The Retinal Stimulator implant eye blind subject surgical operation . However , external component activate test session control investigator team . In first step investigation software control system PC connect Pocket Processor via Ethernet interface , generate define stimulation pattern ( bar , cross , cube ) . During test session , blind subject exposed series stimulation pattern / describe visual perception . Based description interactive way , stimulation signal subsequently modulate change parameter like amplitude , duration impulse , polarity , number repetition pulse frequency PC . In second step visual interface equip camera present realtime image subject . Data obtain investigation computer generate pattern first step use second step improve fit software use camera support system . Finally system enable subject recognize simple image support camera .</detailed_description>
	<mesh_term>Retinitis</mesh_term>
	<mesh_term>Retinitis Pigmentosa</mesh_term>
	<mesh_term>Choroideremia</mesh_term>
	<criteria>Inclusion Criteria Age 30 79 year date enrollment Normal hearing linguistic understanding ( hear aid necessary language hospital English ) Ability understand study procedure involve Willingness participate comply followup procedure Good general health base investigator 's opinion Ability undergo surgery use general anaesthesia Signed informed consent RP , choroideremia , rod cone dystrophy Visual field le 40 ° ( measurable ) Visual acuity better ( 1/50 ) , ( logMAR≥1.7 ) Visual function stable duration least one year ( accord subject statement ) Normal eye pressure ( 921 mmHg ) Bulbus length ( AP ) 21 25 mm Exclusion Criteria Allergic response multiple antibiotic Known allergy material implant Known carrier multiresistant organisms Pregnancy lactate History epileptic seizure Having active implantable device ( need within next 3 year ) Patients cancer patient receive cancer therapy within last 2 year Currently undergo psychiatric treatment without expert opinion approve participation study Patients insufficient mental capacity Neurological disease , particular affect nerve conduction velocity Patients currently take medication affect brain function Immunosuppressive subject</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>Visual Perception</keyword>
	<keyword>Retina</keyword>
	<keyword>Light</keyword>
	<keyword>Retinitis Pigmentosa</keyword>
	<keyword>Visual acuity</keyword>
	<keyword>Retinal Implant</keyword>
	<keyword>Electrical stimulation</keyword>
</DOC>